Children are not just small adults. Specialized experts for tumors in children are needed, who work closely with physicians treating adults. The medical term for adrenal carcinoma (ACC) in childhood is pediatric ACC.
It is now proven that there are fundamental differences in the development and genetic characteristics between tumors in children and adults. Therefore, the findings regarding adrenal cancer cannot be uncritically transferred from adults to children.
Specific Characteristics
Especially in childhood, ACC can be associated with so-called cancer predisposition syndromes, meaning a genetically inherited, familial occurrence of these tumors (e.g., Li-Fraumeni, Lynch or Beckwith-Wiedemann syndromes). Genetic testing is generally recommended for all children with ACC. If a genetic predisposition is identified, it is advisable for family members to undergo genetic testing for the associated syndrome. This may help reduce cancer risk through close monitoring.
In contrast to ACC tumors in adults, almost all tumors in children produce hormones (80% of cases are hormonally active). Primarily, the stress hormone cortisol and male hormone precursors are secreted. However, about 60 percent of those affected actually suffer from hormonal disorders and therefore seek medical help. The main conditions include Cushing’s syndrome (with symptoms such as weight gain, high blood pressure, skin changes, etc.), early puberty development, or abdominal pain.
Generally, the following factors are favorable for the prognosis in children with ACC:
Nevertheless, each case must be considered and assessed individually. No two children are alike. The following steps outline a standard procedure from first checks to various therapy options.
Checks and diagnosis
Comprehensive hormonal tests, especially of the steroid hormones produced in the adrenal cortex, are important. A thorough endocrinological examination at the onset of the disease is important, as it will later be used to assess the response to therapy and detect early recurrence. Imaging techniques such as ultrasound, magnetic resonance imaging (MRI), or positron emission tomography (PET) determine the size and extent of the tumor and any metastases. Regular blood and urine tests are becoming standard.
Surgery
If the disease is limited to the adrenal glands, complete surgical removal of the tumor is the most important first step in therapy. This procedure should be performed in a specialized center with significant experience. It has been shown that the quality of the surgery is a crucial factor for the prognosis. In the ENS@T network, a European association specializing in the study of adrenal tumors: “European Network for the Study of Adrenal Tumors,” a reference surgeon is expected to perform a significant number of adrenal surgeries per year. Relevant experience with pediatric patients can only be developed in larger centers with close interdisciplinary collaboration between pediatric surgeons and experienced tumor surgeons.Please consult the Let’s Cure ACClist of medical experts (including pediatric specialists, accessible to you) or contact us directly for support.
Medical Therapy
After surgery, or for patients who cannot be operated on right away, a medical treatment usually follows, depending on the findings. As with adults, the first-choice medication for children is also Mitotane. For children with advanced-stage disease, additional therapy combinations with chemotherapy or possibly radiation must be carefully considered. In case of recurrence or disease progression despite standard therapies, new therapeutic approaches such as immunotherapy and CAR-T cell therapies can be discussed. A genetic analysis of the tumor (through molecular pathology) to potentially apply a targeted therapy might be another pathway. Medicine continues to make progress and offers new therapeutic possibilities.
Follow-up and Care
All patients with adrenal carcinoma require long-term follow-up care, which should be coordinated between pediatric ACC specialists and local physicians. In addition, connection to a specialized general ACC center, if one exists near your home, is beneficial to quickly implement any necessary therapy changes or new treatment approaches.
Contact and Second Opinion
Since pediatric ACC is very rare, experts worldwide collaborate closely together, both clinically and scientifically. For pediatric tumors, the international working group “KIDS” of ENS@T-PACT has been established. These experts are working closely together with the Brazilian/American working group IC-PACT. Only in this way can children worldwide benefit from medical advances, and the disease be made curable for everyone in the long term.
Within these international networks, the ENSAT-PACT group offers you or your medical team free and non-binding advice or a second opinion. You will find the contact details below and the experts are committed to respond to your inquiries as promptly as possible via phone or email. Please contact: ensatpact@ukw.de
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.